PhRMA, BIO: disclosing drug prices in ads not beneficial to patients

PhRMA and BIO said the passage of a Senate amendment that would require biopharma companies to disclose drug list

Read the full 198 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE